Specific Panels are designed to evaluate groups of genes that are known to be associated with a specific medical condition, clinical presentation, or disease category.

Rather than analyzing a single gene or the entire genome, panel testing focuses on the genes most relevant to the patient’s symptoms. This approach can improve efficiency while providing clinically meaningful results that support diagnosis and management decisions.

Panel testing may be considered in a wide range of situations, including neurological disorders, epilepsy, developmental delay, inherited cancer syndromes, cardiovascular conditions, reproductive genetics, and many other specialized clinical areas.

At Mass Diagnostics, panel testing is coordinated through trusted international partner laboratories with expertise in advanced genomic diagnostics. Our team helps guide test selection, sample collection requirements, laboratory coordination, and report delivery.